The following is a summary of a phone call with the licensee:
A patient was implanted with an I-125 seed of 21.45 millicuries for the radiation therapy. The patient was prescribed to receive radiation therapy to 93.17% of their prostate. Post implant dosimetry indicated that the patient only received a dose to 39.10% of the prostate. There were no unintended health affects as a result of this event.
- * * RETRACTION ON 01/05/2022 AT 1854 EST FROM JIM McKEE TO JEFFREY WHITED * * *
The following is a summary of a phone call with the licensee:
Following discussions with an NRC inspector, the licensee determined that the correct activity had been implanted into the correct area. As such, a medical event did not need to be reported and the licensee retracted the event.
Notified R4DO (Roldan-Otero) and NMSS Event Notification.
A Medical Event may indicate potential problems in a medical facility's use of radioactive materials. It does not necessarily result in harm to the patient.